Compare AstraZeneca plc (AZN) vs Dolby Laboratories, Inc. (DLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Dolby Laboratories, Inc. — how do they compare? AstraZeneca plc trades at $158.09 (market cap $248.14B), while Dolby Laboratories, Inc. trades at $60.91 (market cap $5.75B). The key difference: AstraZeneca plc is far larger — about 43.2× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays the higher dividend (2.35%). Which is the better fit depends on your goals.
| AZN | DLB | |
|---|---|---|
Market Cap | $248.14B | $5.75B |
Sector | Health | Industrials |
52-Week High | $209.48 | $75.62 |
52-Week Low | $147.06 | $48.51 |
Enterprise Value | $275.41B | $5.12B |
Dividend Yield | 2.01% | 2.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →
